Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line

Archives of Oral Biology

Volumn 53, Issue 5, 2008, Pages 443-452

  Zhong, Lai Ping ^a   Pan, Hong Ya ^a   Zhou, Xiao Jian ^a   Ye, Dong Xia ^a   Zhang, Lei ^a   Yang, Xiao ^a   Chen, Wan Tao ^a   Zhang, Zhi Yuan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Benzo(a)pyrene; Carcinogenesis; Human papilloma virus type 16; Immortalization; Oral squamous cell carcinoma

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; ONCOPROTEIN;

ANIMAL; ARTICLE; CANCER INVASION; CELL LINE; CELL PROLIFERATION; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

ANIMALS; BENZO(A)PYRENE; BLOTTING, WESTERN; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS, VIRAL;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS MUSCULUS;

EID: 41049111579     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2007.12.002     Document Type: Article

References (32)

1. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 (2002) 195-215
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
3. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 467-475
4. Hobbs C.G., Sterne J.A., Bailey M., Heyderman R.S., Birchall M.A., and Thomas S.J. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31 (2006) 259-266
5. Pirisi L., Creek K.E., Doniger J., and DiPaolo J.A. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 9 (1988) 1573-1579
6. Park N.H., Min B.M., Li S.L., Huang M.Z., Cherick H.M., and Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12 (1991) 1627-1631
7. Oda D., Bigler L., Lee P., and Blanton R. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp Cell Res 226 (1996) 164-169
8. Sdek P., Zhang Z.Y., Cao J., Pan H.Y., Chen W.T., and Zheng J.W. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 35 (2006) 653-657
9. Popescu N.C., and DiPaolo J.A. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Res 50 (1990) 1316-1323
10. Schmidt B.L., Dierks E.J., Homer L., and Potter B. Tobacco smoking history and presentation of oral squamous cell carcinoma. J Oral Maxillofac Surg 62 (2004) 1055-1058
11. Barasch A., Morse D.E., Krutchkoff D.J., and Eisenberg E. Smoking, gender, and age as risk factors for site-specific intraoral squamous cell carcinoma. A case-series analysis. Cancer 73 (1994) 509-513
12. Romano G., Sgambato A., Boninsegna A., Flamini G., Curigliano G., Yang Q., et al. Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay. Cancer Epidemiol Biomarkers Prev 8 (1999) 91-96
13. Hsu T.M., Zhang Y.J., and Santella R.M. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 6 (1997) 193-199
14. Besaratinia A., Van Straaten H.W., Godschalk R.W., Van Zandwijk N., Balm A.J., Kleinjans J.C., et al. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in mouth floor and buccal mucosa cells of smokers and nonsmokers. Environ Mol Mutagen 36 (2000) 127-133
15. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
16. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3 (2002) 461-469
17. Park N.H., Gujuluva C.N., Baek J.H., Cherrick H.M., Shin K.H., and Min B.M. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10 (1995) 2145-2153
18. Rey O., Baluda M.A., and Park N.H. Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18 (1999) 827-831
19. Zhou H., Lin A., Gu Z., Chen S., Park N.H., and Chiu R. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced c-Jun N-terminal kinase (JNK) phosphatase renders immortalized or transformed epithelial cells refractory to TPA-inducible JNK activity. J Biol Chem 275 (2000) 22868-22875
20. Brown J.J., Qin M., William-Smith L., Coker J.F., Zhou H., Nishitani J., et al. Identification of differentially expressed genes in human papillomavirus type-16 infected oral cancer cells. Otolaryngol Head Neck Surg 124 (2001) 663-668
21. Kang M.K., Kim R.H., Kim S.J., Yip F.K., Shin K.H., Dimri G.P., et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 96 (2007) 126-133
22. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15 (2003) 740-746
23. Chang J.Y., Wright J.M., and Svoboda K.K. Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers. Cells Tissues Organs 185 (2007) 40-47
24. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
25. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
26. Huibregtse J.M., Scheffner M., and Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10 (1991) 4129-4135
27. Scheffner M., Munger K., Huibregtse J.M., and Howley P.M. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J 11 (1992) 2425-2431
28. Imai Y., Matsushima Y., Sugimura T., and Terada M. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol 65 (1991) 4966-4972
29. Munger K., Werness B.A., Dyson N., Phelps W.C., Harlow E., and Howley P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8 (1989) 4099-4105
30. Boyer S.N., Wazer D.E., and Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56 (1996) 4620-4624
31. Kudo Y., Kitajjma S., Sato S., Miyauchi M., Ogawa I., and Takata T. Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis. Oral Oncol 39 (2003) 515-520
32. Itakura M., Mori S., Park N.H., and Bonavida B. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis. Int J Oncol 16 (2000) 591-597